Coronial
TAShospital

Coroner's Finding: Newell, Warren James

Deceased

Warren James Newell

Demographics

71y, male

Date of death

2022-10-01

Finding date

2024-09-30

Cause of death

raised intracranial pressure caused by left frontal-temporal-parietal subdural haemorrhage secondary to coagulopathy from supra-therapeutic enoxaparin dosing, previous rivaroxaban therapy, and dual antiplatelet agents

AI-generated summary

Warren James Newell, a 71-year-old man with oesophageal cancer, presented with acute coronary syndrome on 29 September 2022 and was appropriately diagnosed and treated with anticoagulation and dual antiplatelet therapy. However, he was prescribed an excessive dose of enoxaparin (100 mg twice daily) instead of the weight-appropriate dose of 70 mg twice daily. This supra-therapeutic anticoagulation, combined with rivaroxaban and dual antiplatelet agents, likely contributed to a catastrophic left frontal-temporal-parietal subdural haemorrhage that developed on 1 October 2022, resulting in death. Key preventable factors included failure to weigh the patient on admission, absence of electronic prescribing safeguards, and lack of pharmacist review. Implementation of weight-based dosing protocols, e-prescribing systems, and pharmacy services could have prevented this tragic outcome.

AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.

Specialties

cardiologyemergency medicineneurosurgeryoncologypharmacy

Error types

medicationsystem

Drugs involved

enoxaparinrivaroxabanaspirinclopidogrel

Clinical conditions

acute coronary syndromenon-ST elevation acute coronary syndrome (NSTEACS)left arm deep vein thrombosisoesophageal cancersubdural haemorrhagecoagulopathy

Procedures

PICC line removalECGCT brain scancoronary angiography (planned)

Contributing factors

  • excessive enoxaparin dose (100 mg twice daily instead of 70 mg twice daily)
  • failure to weigh patient on admission
  • weight not recorded on medication chart
  • no electronic prescribing system to flag excessive dose
  • no pharmacist for emergency department to identify dosing error
  • combination of anticoagulation (rivaroxaban, enoxaparin) and dual antiplatelet therapy (aspirin, clopidogrel) creating significant bleeding risk

Coroner's recommendations

  1. Improved practices for recording patient weight on admission
  2. Placement of correct enoxaparin dosages in guidelines
  3. Implementation of electronic prescribing system
  4. Establishment of pharmacist service for emergency department
  5. Alleviation of workload in relevant circumstances
  6. Tasmanian Health Service and MCH to revisit RCA recommendations and assess whether further action should be taken to enhance accurate use of drugs
Full text

Source and disclaimer

This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.

Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.

Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.